Introduction: Prostate cancer is one of the most common malignant neoplasms among men, especially after the age of 60. It originates from the uncontrolled proliferation of cells in prostate tissue. Structural and functional changes in the prostate — the gland responsible for producing seminal fluid — may indicate the presence of the disease. Objective: To analyze the epidemiological profile of prostate cancer mortality in the state of Pará from 2020 to 2023, identifying demographic and regional patterns in comparison with the overall Northern Region of Brazil. Methods: This is an ecological, descriptive, and retrospective study based on secondary data obtained from the TabNet platform, managed by the Department of Informatics of the Brazilian Unified Health System (DATASUS). Deaths from malignant neoplasm of the prostate (ICD-10: C61) recorded in the Mortality Information System (SIM) between 2020 and 2023 were analyzed. The geographic area of interest included the state of Pará and the entire Northern Region, aiming to perform a comparative analysis. The variables considered were the place of occurrence and the year of death. Data were extracted from the “Deaths by Occurrence” section and tabulated in Microsoft Excel® for organization and proportion calculations. Results: From 2020 to 2023, a total of 3,695 deaths from malignant neoplasm of the prostate were registered in the Northern Region of Brazil. The annual distribution was: 881 in 2020, 922 in 2021, 871 in 2022, and 1,011 in 2023. A relative fluctuation was observed in the initial years, followed by a notable upward trend in 2023, which marked the highest number of deaths during the period. In the state of Pará alone, 1,585 deaths were recorded: 403 in 2020, 392 in 2021, 371 in 2022, and 419 in 2023—representing over 42% of the total regional deaths in this four-year span. Notably, Pará showed a slight decline in deaths from 2020 to 2022, followed by an increase of approximately 13% in 2023. It remained the state with the highest absolute number of prostate cancer deaths in the Northern Region. The remaining 57.1% of deaths were distributed across the other six states (Amazonas, Acre, Roraima, Rondônia, Amapá, and Tocantins), consistently highlighting Pará as the most affected federative unit. Conclusion: The high number of prostate cancer deaths in Pará, compared to the rest of the Northern Region, reflects sociodemographic disparities in access to screening, diagnosis, and treatment—particularly in areas outside the state capital. Therefore, expanding targeted screening strategies in the most vulnerable areas is essential to reduce prostate cancer mortality and promote equity in health care access.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
